Status:
COMPLETED
Brazilian Coronary ARtery Disease
Lead Sponsor:
University of Sao Paulo General Hospital
Conditions:
Coronary Artery Disease
Eligibility:
All Genders
18-80 years
Brief Summary
Although coronary artery disease may have a stable chronic clinical course, it is known that this reality does not apply to atherosclerotic plaques, they can grow, complicate, stabilize and again star...
Detailed Description
Introduction: For decades, patients with obstructive coronary disease, specifically with lesions above 70%, have been the subject of numerous randomized studies and meta-analyses concerning the influ...
Eligibility Criteria
Inclusion
- • Patients referred to Instituto do Coração (InCor HC, FM-USP) for invasive coronary angiography or angiotomography.
Exclusion
- Age under 18 years or over 80 years at the time of examination;
- Previous history of acute coronary syndrome (infarction and unstable angina);
- Revascularization interventions (surgical or percutaneous);
- Valvular heart disease;
- Cardiomyopathies;
- Diseases with a poor prognosis (expected survival of less than 8 years).
Key Trial Info
Start Date :
June 1 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 1 2024
Estimated Enrollment :
4004 Patients enrolled
Trial Details
Trial ID
NCT05392491
Start Date
June 1 2022
End Date
November 1 2024
Last Update
May 4 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Instituto do Coração InCor, Hospital das Clínicas HCFMUSP, Faculdade de Medicina, Universidade de São Paulo
São Paulo, São Paulo, Brazil, 05403-000